Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease
Clinical trial NCT05105230 · UNKNOWN
Trial details
- NCT number
- NCT05105230
- Sponsor
- Assiut University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-04-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.